Connection

Carsten Krieg to Neoplasms, Experimental

Back to Details
This is a "connection" page, showing publications Carsten Krieg has written about Neoplasms, Experimental.
Carsten Krieg
Connection Strength
0.150
Neoplasms, Experimental
  1. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.